Paola Gimeno-Gracia
Zaragoza, AR 50015, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 16, 2026
Asynchronous telerehabilitation in prehabilitation and postoperative recovery for colorectal cancer: A protocol for a randomized controlled trial.
Journal: PloS one
Published: October 07, 2025
Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain.
Journal: Journal of clinical medicine
Published: September 23, 2025
Impact of presurgical beta-blockade on surgical outcomes in patients with PPGLs.
Journal: Endocrine-related cancer
Published: August 11, 2025
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Journal: Endocrine-related cancer
Published: July 26, 2024
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Journal: Endocrine-related cancer
Published: March 02, 2024
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.
Journal: Frontiers in endocrinology
Published: November 10, 2023
Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
Journal: Journal of hypertension
Published: October 18, 2023
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register.
Journal: Endocrine
Published: August 23, 2023
Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Journal: Frontiers in endocrinology
Published: August 18, 2023
Last Updated: 09/26/2026